Private company

HTG MOLECULAR DIAGNOSTICS, INC

HTG MOLECULAR DIAGNOSTICS, INC is an American laboratory analytical instruments company based in Tucson.2

Last updated Oct 20, 2026.

Overview

  • IndustryLaboratory Analytical Instruments2
  • HeadquartersTucson, United States2
  • Incorporated inDE3
  • Business address3430 E. Global Loop, Tucson, Az 857063
  • Filer categoryNon-accelerated filer, Smaller reporting company3
  • Legal formCorporation2
  • LEI5493001QFG6NIN60NK562
  • StatusActive2
  • LEI statusLapsed (not renewed)2
  • Registered addressC/O CORPORATION SERVICE COMPANY, 19808 Wilmington, United States2
  • Registered withDivision of Corporations, Department of State, 33290492

See how the biggest companies compare on our leaderboards

Financials

From the company’s reports to the SEC. Every number links to the filing it came from.

Key numbers, fiscal 2022

-327.2%Operating margin4
-339.2%Net margin4
-28.5%Revenue growth, 20224
-400.5%Return on equity4
-$18.4MFree cash flow4

Where the money goes

Where each dollar of revenue went, fiscal 2022

  • Cost of revenue16¢$4.6M
  • Research and development24¢$6.8M
  • Selling, general and admin56¢$15.8M
  • Interest3¢$856.7K
  • Income tax0¢$10.8K

Out of $6.4M in revenue.4 The company lost money this year.

Financial statements

Revenue567894$6.4M in 2022+24% since 2016
0$10.0M$20.0M$30.0M2016: $5.1M$5.1M20162017: $14.8M$14.8M2017+188%2018: $21.5M$21.5M2018+46%2019: $19.2M$19.2M2019−11%2020: $8.5M$8.5M2020−55%2021: $8.9M$8.9M2021+4%2022: $6.4M$6.4M2022−29%
Gross profit5$9.8M in 2017+882% since 2016
0$2.5M$5.0M$7.5M$10.0M2016: $996.8K$996.8K20162017: $9.8M$9.8M2017+882%
Operating income567894-$20.8M in 2022−14% since 2016
-$30.0M-$20.0M-$10.0M02016: -$24.3M-$24.3M20162017: -$17.7M-$17.7M2017−27%2018: -$16.2M-$16.2M2018−9%2019: -$19.0M-$19.0M2019+17%2020: -$19.6M-$19.6M2020+3%2021: -$17.8M-$17.8M2021−9%2022: -$20.8M-$20.8M2022+17%
Net income567894-$21.6M in 2022−17% since 2016
-$30.0M-$20.0M-$10.0M02016: -$26.0M-$26.0M20162017: -$19.0M-$19.0M2017−27%2018: -$16.5M-$16.5M2018−13%2019: -$19.3M-$19.3M2019+17%2020: -$20.9M-$20.9M2020+8%2021: -$17.1M-$17.1M2021−18%2022: -$21.6M-$21.6M2022+26%
Fiscal year2016201720182019202020212022
Revenue$5.1M5$14.8M6$21.5M7$19.2M8$8.5M9$8.9M4$6.4M4
Cost of revenue$4.1M5$5.0M5$5.1M7$8.9M8$4.0M9$4.1M4$4.6M4
Gross profit$996.8K5$9.8M5
Research and development$7.9M5$10.0M6$12.6M7$10.6M8$6.1M9$6.1M4$6.8M4
Selling, general and admin$17.4M5$17.5M6$20.0M7$18.7M8$18.1M9$16.5M4$15.8M4
Operating expenses$26.7M4$27.2M4
Operating income-$24.3M5-$17.7M6-$16.2M7-$19.0M8-$19.6M9-$17.8M4-$20.8M4
Interest$1.9M5$1.3M6$901.8K7$957.5K8$1.0M9$1.1M4$856.7K4
Income before tax-$17.1M4-$21.6M4
Income tax$10.1K5$2.9K6$3.5K7$3.4K8$14.4K9$22.5K4$10.8K4
Net income-$26.0M5-$19.0M6-$16.5M7-$19.3M8-$20.9M9-$17.1M4-$21.6M4
Earnings per share-$29.664-$24.284
Earnings per share (diluted)-$29.664-$24.284
Shares (weighted, basic)578.0K shares4889.3K shares4
Shares (weighted, diluted)578.0K shares4889.3K shares4

Compare HTG MOLECULAR DIAGNOSTICS, INC with another company

Corporate structure

HTG MOLECULAR DIAGNOSTICS, INC sits at the top of its group. 1 entity, 1 country on record. Switch between the flow chart and the network, and select any entity to see its details.

Major holders of HTG MOLECULAR DIAGNOSTICS, INC

  • Laurence W. Lytton Filed SC 13G/A on HTG MOLECULAR DIAGNOSTICS, INC, latest Feb 13, 2023 (2 filings since Feb 15, 2022)
  • Samjo Capital LLC Filed SC 13G/A on HTG MOLECULAR DIAGNOSTICS, INC, latest Feb 10, 2023 (2 filings since Feb 8, 2022)
  • Cowen Prime Advisors LLC Filed SC 13G on HTG MOLECULAR DIAGNOSTICS, INC, latest Feb 3, 2023 (2 filings since Feb 9, 2022)
  • Hewlett Fund LP Filed SC 13G/A on HTG MOLECULAR DIAGNOSTICS, INC, latest Jul 28, 2022 (2 filings since Jan 4, 2022)
  • L5 Capital Inc. Filed SC 13G/A on HTG MOLECULAR DIAGNOSTICS, INC, latest Jul 18, 2022 (2 filings since Jun 29, 2022)
  • Orin Hirschman Filed SC 13G/A on HTG MOLECULAR DIAGNOSTICS, INC, latest Mar 31, 2022 (2 filings since Feb 11, 2022)
  • Nantahala Capital Management, LLC Filed SC 13G/A on HTG MOLECULAR DIAGNOSTICS, INC, latest Feb 14, 2022
  • HTG MOLECULAR DIAGNOSTICS, INC Tucson, Arizona, United States

Built from parent and subsidiary links from GLEIF, the Global Legal Entity Identifier Foundation (CC0); major holders from Schedules 13D and 13G. Each entity in the chart links to its source.

What it owns

What HTG MOLECULAR DIAGNOSTICS, INC reports owning in its annual reports to the SEC: buildings, land and equipment, real estate and locations, investments, intangible assets and inventory, at the end of its latest fiscal year and a year before.

Property and equipment

ItemLatestA year beforeChange
Machinery and equipment$1.9M4 Dec 31, 2022$2.4M4 Dec 31, 2021−23.4%
Furniture and fixtures$756.1K4 Dec 31, 2022$872.9K4 Dec 31, 2021−13.4%
Computer equipment and software$469.4K4 Dec 31, 2022$480.7K4 Dec 31, 2021−2.4%
Leasehold improvements$1.9M4 Dec 31, 2022$1.9M4 Dec 31, 2021+0.4%
Property and equipment, before depreciation$7.3M4 Dec 31, 2022$8.3M4 Dec 31, 2021−12.2%
Accumulated depreciation$6.7M4 Dec 31, 2022$7.2M4 Dec 31, 2021−6.8%
Property and equipment, net$598.0K4 Dec 31, 2022$1.1M4 Dec 31, 2021−46.6%
Finance-lease assets$43.7K9 Dec 31, 2021$66.8K8 Dec 31, 2020−34.6%
Operating-lease assets (leased space)$1.0M4 Dec 31, 2022$1.3M4 Dec 31, 2021−25.1%

Investments

ItemLatestA year beforeChange
Cash and cash equivalents$12.2M4 Dec 31, 2022$9.6M4 Dec 31, 2021+27.2%
Marketable securities, current$04 Dec 31, 2022$12.3M4 Dec 31, 2021−100.0%
Debt securities available for sale$04 Dec 31, 2022$12.3M4 Dec 31, 2021−100.0%

Inventory

ItemLatestA year beforeChange
Inventory, total$909.3K4 Dec 31, 2022$2.0M4 Dec 31, 2021−54.3%
Raw materials$426.5K4 Dec 31, 2022$1.3M4 Dec 31, 2021−66.0%
Work in process$113.1K4 Dec 31, 2022$312.8K4 Dec 31, 2021−63.9%
Finished goods$394.0K4 Dec 31, 2022$447.1K4 Dec 31, 2021−11.9%

Leadership

Who has led HTG MOLECULAR DIAGNOSTICS, INC, and when. Pick a name to see everywhere that person has worked.

Chief executive

  1. John L. Lubniewski2019–2022

President

  1. John L. Lubniewski2018–2022

Chief financial officer

  1. Shaun D. McMeans2015–2022

Chief operating officer

  1. John L. Lubniewski2018–2019
20202025
Board members and other officers (20)

Named in SEC Form D filings

People the company listed in its private-offering notices.

  • DirectorMichelle R. Griffin named Mar 25, 202235

Former names

  • HTG MOLECULAR DIAGNOSTICS INCJun 17, 2011 to Nov 14, 20123
  • HIGH THROUGHPUT GENOMICS INCMar 1, 2002 to Mar 1, 20113

Timeline

  1. Jun 8, 20238-K Listing notice or transfer36
  2. Jun 5, 20238-K Bankruptcy or receivership; Debt or obligation accelerated; Executive or director change37
  3. May 24, 20238-K Listing notice or transfer38
  4. May 16, 20238-K Other events39
  5. May 10, 20238-K Results of operations40
  6. Apr 25, 20238-K Other events41
  7. Feb 3, 20238-K Executive or director change42
  8. Jan 6, 20238-K Results of operations43
  9. Dec 29, 20228-K Other events44
  10. Dec 23, 20228-K Other events45
  11. Dec 20, 20228-K Change to shareholders' rights46
  12. Dec 12, 20228-K Other events47
  13. Apr 1, 2019New chief executive John L. Lubniewski becomes CEO13
  14. Dec 14, 2000Founded HTG MOLECULAR DIAGNOSTICS, INC is founded2

Calendar

When it reported results

  1. May 10, 2023Reported quarterly or annual results40
  2. Jan 6, 2023Reported quarterly or annual results43
  3. Nov 10, 2022Reported quarterly or annual results48
  4. Aug 11, 2022Reported quarterly or annual results49
  5. May 12, 2022Reported quarterly or annual results50
  6. Mar 29, 2022Reported quarterly or annual results51
  7. Jan 6, 2022Reported quarterly or annual results52
  8. Nov 10, 2021Reported quarterly or annual results53

Upcoming dates from Nasdaq's calendar; past results from the company's 8-K filings (Item 2.02). The full markets calendar

Filings

119 filings to the SEC since October 2021: 2 annual reports, 5 quarterly reports, 29 major events, 41 insider forms, 13 large holders, 1 private raises, 28 other. The latest 20:

  1. Jul 10, 202325-NSE EDGAR
  2. Jun 9, 20234 FORM 4 SUBMISSION EDGAR
  3. Jun 8, 20238-K EDGAR
  4. Jun 5, 20238-K EDGAR
  5. May 24, 20238-K EDGAR
  6. May 16, 20238-K EDGAR
  7. May 11, 202310-Q EDGAR
  8. May 10, 20238-K EDGAR
  9. Apr 25, 20238-K EDGAR
  10. Apr 7, 20234 FORM 4 SUBMISSION EDGAR
  11. Mar 30, 202310-K EDGAR
  12. Feb 13, 2023SC 13G/A EDGAR
  13. Feb 10, 20233 FORM 3 SUBMISSION EDGAR
  14. Feb 10, 2023SC 13G/A EDGAR
  15. Feb 3, 20238-K EDGAR
  16. Feb 3, 2023SC 13G EDGAR
  17. Jan 6, 20238-K EDGAR
  18. Dec 29, 20228-K EDGAR
  19. Dec 23, 20228-K EDGAR
  20. Dec 22, 2022424B4 EDGAR

The 119 filings since October 2021 can be filtered by form type and year here when JavaScript is on.

Every filing from the last five years, summarized. The full record is on SEC EDGAR.

Insider trades

1 open-market trades by officers, directors and large owners since October 2021: 0 buys and 1 sales. Grants, option exercises and gifts are left out.

DateWhoTradeSharesPriceValueFiling
Jun 8, 2023Barat StephenSenior VP of TherapeuticsSale888$0.80$710Form 4

From Forms 4 filed with the SEC.

Major holders

Investors who own more than 5% of the shares must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively.

Money raised

Private offerings the company reported to the SEC on Form D.

  1. Mar 21, 2022Raised $7.5 million in a private offering of equity Form D: $20.9 million offered in all Form D

SEC filer profile

How HTG MOLECULAR DIAGNOSTICS, INC is registered with the Securities and Exchange Commission, from its EDGAR record and the cover page of its latest annual report.

  • Name on EDGARHTG MOLECULAR DIAGNOSTICS, INC1
  • CIK0001169987
  • Employer ID (EIN)86-09122941
  • Filer statusNon-accelerated filer<br>smaller reporting company1
  • Incorporated inDelaware1
  • Fiscal year endsDecember 311
  • Industry code (SIC)3826 Laboratory Analytical Instruments1
  • Business address3430 E. Global Loop, Tucson, AZ 857061
  • Phone877-289-26151
  • Shares outstanding2,214,233 as of May 5, 202312
  • Public float$11.3M as of Jun 30, 20224
  • On EDGAR sinceMar 1, 20021
  • Filings669 in all: 4 (265), 8-K (140), SC 13G/A (30), 3 (28), 10-Q (25), SC 13G (19), CT ORDER (18), CORRESP (14)1
    All 34 form types

    424B5 (12), S-8 (11), SC 13D/A (11), DEFA14A (10), REGDEX (9), UPLOAD (9), 10-K (8), D (8), DEF 14A (8), 4/A (7), EFFECT (7), S-3 (5), PRE 14A (3), S-1/A (3), SC 13D (3), 424B4 (2), CERTNAS (2), D/A (2), DRSLTR (2), S-1 (2), 25-NSE (1), 8-A12B (1), DRS (1), DRS/A (1), POS EX (1), REGDEX/A (1)

  • Latest filingsAnnual report (10-K) Mar 30, 2023
    Quarterly report (10-Q) May 11, 2023
    Proxy statement (DEF 14A) Oct 31, 2022
    Latest 8-K (8-K) Jun 8, 2023

Sources

The numbers on this page point here. Each one links to the record it came from.

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20
  21. 21
  22. 22
  23. 23
  24. 24
  25. 25
  26. 26
  27. 27
  28. 28
  29. 29
  30. 30
  31. 31
  32. 32
  33. 33
  34. 34
  35. 35
  36. 36
  37. 37
  38. 38
  39. 39
    SEC EDGAROther events
  40. 40
  41. 41
    SEC EDGAROther events
  42. 42
  43. 43
  44. 44
    SEC EDGAROther events
  45. 45
    SEC EDGAROther events
  46. 46
  47. 47
    SEC EDGAROther events
  48. 48
  49. 49
  50. 50
  51. 51
  52. 52
  53. 53
  54. 54
  55. 55
  56. 56
  57. 57
  58. 58
  59. 59
  60. 60